T1	Participants 310 358	Fifty consecutive patients undergoing vitrectomy
T2	Participants 437 445	patients
T3	Participants 554 570	diclofenac group
T4	Participants 875 885	two groups
T5	Participants 961 977	diclofenac group
T6	Participants 1069 1079	two groups
T7	Participants 1252 1265	control group
T8	Participants 1329 1334	group
T9	Participants 1283 1291	patients
